The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMalvern Intl Regulatory News (MLVN)

Share Price Information for Malvern Intl (MLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.00
Bid: 19.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 2.00 (10.526%)
Open: 20.00
High: 20.00
Low: 20.00
Prev. Close: 20.00
MLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and GM

11 Jun 2018 14:10

RNS Number : 0031R
Malvern International PLC
11 June 2018
 

11 June 2018

Malvern International plc

(AIM: MLVN)

 

Result of Annual General Meeting

Result of General Meeting

 

Malvern International plc ("Malvern" or the "Company"), the global learning and skills development partner, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

 

In addition, the Company announces that at the General Meeting also held today, all resolutions were duly passed, including resolutions to approve a sub-division of the existing share capital and the issue of the Placing Shares and the Consideration Shares, details of which were set out in a circular to shareholders dated 17 May 2018.

 

The Placing of 100,000,000 New Ordinary Shares at a price of 4p per Placing Share has raised £4 million, before expenses, for the Company. The net proceeds of the Fundraising are expected to be approximately £3.725 million. These proceeds will be applied in satisfying the cash consideration of £1.65 million due in respect of the acquisition of Communicate English Schools Limited. The balance of the proceeds will be used to support the future growth of the business.

The acquisition of Communicate English Schools Limited is expected to complete on 2 July 2018. Admission of the 13,800,000 Consideration Shares is expected to take place on 3 July 2018.

CG Corp and KSP Investments Pte Limited ("KSP"), the Company's two largest shareholders subscribed for 8,700,000 and 9,325,000 New Ordinary Shares respectively in the Placing. Each of CG Corp and KSP's participation in the Placing constitutes a related party transaction under Rule 13 of the AIM Rules. Sam Malafeh and Hock Kee Wee are the independent directors for the purposes of these transactions, and consider, having consulted with WH Ireland Limited, the Company's nominated adviser, that the terms of CG Corp and KSP's participation in the Placing are fair and reasonable insofar as the shareholders of the Company are concerned.

Application for admission to trading on AIM has been made in respect of the New Ordinary Shares arising from the Sub-division and the Placing, being in aggregate 214,188,333 Ordinary Shares of 1p each, and admission is expected to take place on 12 June 2018.

 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following these issues, its issued share capital will comprise 214,188,333 Ordinary Shares of 1p each. All of these Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company will therefore be 214,188,333 on Admission. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

 

This announcement should be read in conjunction with the full text of the Circular posted to Shareholders on 17 May 2018, copies of which are available on the Company's website at www.malverninternational.com. Capitalised terms in this announcement have the same meaning as given in the Circular.

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

For further information please contact:

 

Malvern International Plc

www.malverninternational.com

Dr Sam Malafeh - Chief Executive Officer

Via Walbrook PR

Navin Khattar - Non-Executive Director

malvern@walbrookpr.com

WH Ireland (NOMAD & Broker)

www.whirelandcb.com

Mike Coe / Ed Allsopp

+44 117 945 3470

Walbrook PR

+44 20 7933 8780

Tom Cooper / Paul McManus

+44 797 122 1972

tom.cooper@walbrookpr.com

 

 

 

Notes to Editors:

Malvern International is a global learning and skills development partner preparing students and learners to meet the demands of a professional life. Courses are delivered on sites in London, Singapore, and Malaysia; with the option of studying across multiple campus' over the duration of the same course; and online through the Malvern Online Academy - making step change education accessible while taking part in the learner's journey to success.

Courses include:

· Certificate, Diploma and pre-University programs;

· University degree and post-graduate programs;

· Courses for professional examinations;

· Tuition services for secondary school students and English language teaching.

 

Established in the 1980's and admitted to AIM in 2004, Malvern employs approximately 250 people and delivers a wide range of courses. Malvern's growth strategy is driven by organic growth initiatives complemented by strategic acquisitions. For further investor information go to www.malverninternational.com www.walbrookpr.com/malvern

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMGGURUQUPRGWG
Date   Source Headline
23rd Apr 20247:00 amRNSAnnual Report & Notice of AGM
10th Apr 20247:00 amRNSFinal Results
4th Mar 202412:00 pmRNSIssue of Warrants
14th Feb 202411:02 amRNSCorrection: Trading Update
15th Jan 20245:22 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSContract extension
15th Nov 20237:00 amRNSAppointment of CDO & Grant of EMI Options
3rd Oct 20237:00 amRNSClosure of Malvern House, Brighton
29th Sep 20237:00 amRNSInterim Results
24th Aug 20237:00 amRNSTrading Update
30th May 202312:37 pmRNSResult of AGM
30th May 20237:00 amRNSTrading Update
15th May 20237:00 amRNSPartnership Agreement
26th Apr 20237:00 amRNSAnnual Report & Notice of Annual General Meeting
12th Apr 20234:23 pmRNSDirector Dealing
12th Apr 20237:00 amRNSDirector Dealing
6th Apr 20237:00 amRNSFinal Results
3rd Apr 202310:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSTrading Update
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20234:40 pmRNSSecond Price Monitoring Extn
19th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Nov 20224:11 pmRNSGrant of Options
10th Nov 20221:48 pmRNSDirectors Dealing
10th Nov 202210:36 amRNSHolding(s) in Company
10th Nov 202210:31 amRNSDirectors Dealing
10th Nov 20227:00 amRNSPlacing and Total Voting Rights
2nd Nov 20223:31 pmRNSCorrection: Result of General Meeting and TVR
2nd Nov 202211:44 amRNSResult of General Meeting and Total Voting Rights
2nd Nov 20227:00 amRNSTrading Update
17th Oct 20227:00 amRNSShare Reorganisation an Notice of General Meeting
17th Oct 20227:00 amRNSShare Reorganisation and Notice of General Meeting
4th Oct 20224:24 pmRNSHolding(s) in Company
29th Sep 20228:23 amRNSHolding(s) in Company
27th Sep 20228:25 amRNSDirector dealings
22nd Sep 20228:42 amRNSDirector dealings
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20227:00 amRNSHalf-year Report
25th Aug 20227:00 amRNSTrading update
9th Aug 20225:11 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSLoan Conversion and Issue of Equity
8th Jun 202211:33 amRNSResult of AGM & Director Disclosure
23rd May 20227:00 amRNSContract award
4th May 20227:00 amRNSFinal Results
4th Mar 20227:00 amRNSDebt restructuring
4th Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.